Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CTR20261421 Soficitinib Dermatitis, Atopic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
CTR20261421 clinical trial report covering Soficitinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07570758 ERX 1000 analogues (ERX Pharmaceuticals) Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07570758 clinical trial report covering ERX 1000 analogues (ERX Pharmaceuticals), Phase 2, endpoints, sponsor, geography, readout timing and development wh
Latest Hotspot
8 min read
NCT07570914 Irinotecan Hydrochloride Lioposome Liver metastases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07570914 clinical trial report covering Irinotecan Hydrochloride Lioposome, Phase 2, endpoints, sponsor, geography, readout timing and development white sp
Latest Hotspot
8 min read
NCT07569198 Ketamine Hydrochloride Borderline Personality Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07569198 clinical trial report covering Ketamine Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07569159 Methylenedioxymetamfetamine Stress Disorders, Post-Traumatic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07569159 clinical trial report covering Methylenedioxymetamfetamine, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07570862 FT-819 Lupus Nephritis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07570862 clinical trial report covering FT-819, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07569965 Fludarabine Phosphate Mantle-Cell Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07569965 clinical trial report covering Fludarabine Phosphate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261766 Interferon alpha-2b (Beijing Kawin Technology) Herpangina Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
CTR20261766 clinical trial report covering Interferon alpha-2b (Beijing Kawin Technology), Phase 2, endpoints, sponsor, geography, readout timing and developm
Latest Hotspot
8 min read
CTR20261735 CG-001(ComGen) Hemoglobinuria, Paroxysmal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
CTR20261735 clinical trial report covering CG-001(ComGen), Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07574385 ALX006(AILUX) Hallux Valgus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07574385 clinical trial report covering ALX006(AILUX), Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07572396 (-)-Epigallocatechin Gallate Congenital Abnormalities Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07572396 clinical trial report covering (-)-Epigallocatechin Gallate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07572552 Silibinin Sepsis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07572552 clinical trial report covering Silibinin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.